These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17698254)

  • 1. Noladin ether, a putative endocannabinoid, inhibits mu-opioid receptor activation via CB2 cannabinoid receptors.
    Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S
    Neurochem Int; 2008 Jan; 52(1-2):321-8. PubMed ID: 17698254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB(2) cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB(2) receptor in pain.
    Páldy E; Bereczki E; Sántha M; Wenger T; Borsodi A; Zimmer A; Benyhe S
    Neurochem Int; 2008 Dec; 53(6-8):309-16. PubMed ID: 18804501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids.
    Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S
    Acta Biol Hung; 2007; 58 Suppl():113-29. PubMed ID: 18297798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors.
    Zádor F; Otvös F; Benyhe S; Zimmer A; Páldy E
    Neurochem Int; 2012 Aug; 61(3):378-88. PubMed ID: 22613132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
    Shoemaker JL; Joseph BK; Ruckle MB; Mayeux PR; Prather PL
    J Pharmacol Exp Ther; 2005 Aug; 314(2):868-75. PubMed ID: 15901805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
    Cinar R; Szücs M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors.
    Shapira M; Vogel Z; Sarne Y
    Cell Mol Neurobiol; 2000 Jun; 20(3):291-304. PubMed ID: 10789829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.
    Levitt ES; Purington LC; Traynor JR
    Mol Pharmacol; 2011 Mar; 79(3):461-71. PubMed ID: 21098043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2.
    Fattore L; Viganò D; Fadda P; Rubino T; Fratta W; Parolaro D
    Eur J Neurosci; 2007 Apr; 25(7):2191-200. PubMed ID: 17419755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
    Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J
    Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice.
    Berrendero F; Mendizábal V; Murtra P; Kieffer BL; Maldonado R
    Eur J Neurosci; 2003 Oct; 18(8):2197-202. PubMed ID: 14622180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors.
    Canals M; Milligan G
    J Biol Chem; 2008 Apr; 283(17):11424-34. PubMed ID: 18319252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
    Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
    J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.
    Chakass D; Philippe D; Erdual E; Dharancy S; Malapel M; Dubuquoy C; Thuru X; Gay J; Gaveriaux-Ruff C; Dubus P; Mathurin P; Kieffer BL; Desreumaux P; Chamaillard M
    Gut; 2007 Jul; 56(7):974-81. PubMed ID: 17299060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene.
    Mizoguchi H; Wu HE; Narita M; Loh HH; Nagase H; Tseng LF
    Neurosci Lett; 2002 Dec; 335(2):91-4. PubMed ID: 12459506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
    Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
    Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.